What puberty blockers actually do to the body

Where the confusion comes from

In a televised debate, a claim was made that puberty blockers "switch off your ovaries or your testicles" and that the hormone switched off is then replaced with "the opposite hormone so that their body's secondary sex characteristics develop in line with their gender identity." That framing collapses two distinct medical interventions into one, and it gets the mechanism of the first one wrong. Both errors matter, and I want to take them apart carefully, because the people who pay the price for this kind of confusion are young trans people and their families trying to make informed decisions.

What GnRH agonists actually do

GnRH agonists, the medications most commonly described as puberty blockers, work at the level of the pituitary gland. The pituitary sits at the base of the brain and acts as a relay station: it receives signals from the hypothalamus and in turn sends its own signals, called gonadotrophins, down to the gonads. Those gonadotrophins tell the ovaries or testicles to produce oestrogen or testosterone, which is what drives the physical changes of puberty.

A GnRH agonist interrupts that relay. It occupies the receptor that would normally receive the hypothalamus signal, and because it stays there continuously rather than pulsing the way the body's own GnRH does, the pituitary essentially stops responding. Gonadotrophin production drops, and without that signal the gonads produce very little sex hormone. Puberty pauses.

The gonads themselves, the ovaries or the testicles, are not switched off. They are not removed, damaged, or shut down. They sit there, intact, simply not receiving the instruction to produce hormones. That is an important biological distinction, because it is the basis for the claim that blockers are reversible: stop the medication, the pituitary signal resumes, the gonads respond, and puberty restarts. The body's own machinery has not been dismantled.

GnRH agonists have been used in medicine since the 1980s, initially for a condition called precocious puberty, where children begin puberty far too early. That history is worth naming, because it means decades of data on what these medications do and do not do, long before anyone was discussing their use in the context of gender care.

Why the "switched off" framing is misleading

Language like "switching off the ovaries" implies an organ that has been deactivated, disabled, or permanently altered. It invites the listener to imagine something more drastic and more irreversible than what is actually happening. In a debate where the audience has no particular medical background, that image does real work: it makes a temporary hormonal pause sound like a surgical intervention.

It also subtly shifts the weight of the decision. If the ovaries are being "switched off", the question becomes whether that is acceptable. If the pituitary relay is being quietened so that a young person has time to think, the question becomes something rather different: whether more time, and freedom from an unwanted puberty progressing in the background, is a reasonable thing to offer someone who needs it.

Those are not the same question, and they do not lead to the same conversation.

Cross-sex hormones are an entirely separate step

The second error in the claim is the suggestion that giving blockers automatically involves replacing the suppressed hormone with "the opposite hormone". That is not how this works.

Cross-sex hormones, oestrogen for trans girls and women, testosterone for trans boys and men, are a separate intervention. They are considered separately, discussed separately, consented to separately, and started at a different time. A young person on puberty blockers is not automatically on cross-sex hormones. Many are not. The two conversations have different timelines and different decision points, and treating them as a single combined treatment muddies both.

Why does that matter? Because one of the things puberty blockers are designed to do is create space: time for a young person to live in a paused state, to continue thinking about who they are and what they want, without the pressure of an unwanted puberty advancing in the meantime. If we present blockers and hormones as a single package deal, we erase that space conceptually before it has been used. We turn a pause into a conveyor belt in the listener's imagination, which is not what it is in practice.

The decision to start cross-sex hormones, when and if it is made, involves its own assessment, its own discussion of effects and timelines and fertility implications, and its own consent. It is a considered step, not an automatic consequence of having taken blockers.

What reversibility actually means

The reversibility of puberty blockers is sometimes discussed as though it were a contested or uncertain claim. It is not. When a GnRH agonist is stopped, puberty resumes. That is the mechanism: the pituitary relay restarts, the gonads receive their signal again, and sex hormone production returns. The physical changes of puberty that had been paused then continue.

This is why the "switch off the gonads" framing is not just imprecise but actively misleading: it implies a kind of damage that is not occurring. The machinery is not being harmed. It is being quietened, and quietening something is, by definition, reversible in a way that switching it off is not.

There are genuine questions worth asking about long-term use of GnRH agonists, including effects on bone density over time and the implications for fertility if a person subsequently does not pursue gonadal hormone production in any form. Those are real clinical considerations, and they are part of what a thorough informed consent process covers. But they are different questions from the one implied by the "switched off ovaries" framing, and conflating them does not help anyone think clearly.

Why this distinction matters for families and young people

Many of the families I hear from are trying to make a genuinely difficult decision with whatever information they can find. When public claims about what blockers do are inaccurate, those families are working from a distorted picture. A parent who believes that starting blockers means their child's ovaries will be switched off and immediately replaced by "the opposite hormone" is not in a position to give properly informed consent to anything, because what they think is happening is not what is happening.

Accurate information is not a political position. It is the precondition for good decision-making. The mechanism of GnRH agonists is not contested science: it is pharmacology, and it has been understood for decades. What the medication does, and what it does not do, is knowable, and families deserve to know it clearly.

Puberty blockers buy time. That time belongs to the young person using it. Cross-sex hormones are a separate conversation that may or may not follow. And the gonads, throughout, remain intact.